News
LIVE WEBINAR 17.04 | Innovations and Future Outlook in Radiotheranostics
LIVE WEBINAR 17.04 | Innovations and Future Outlook in Radiotheranostics
See more
Supporting Cancer Care through European and National Research Projects Collaboration
IBA RadioPharma Solutions is proud to participate in several innovative projects focused on advancing precision Oncology and Theranostics: Accelerate.EU and Innovative Industrial Target Preparation (IITP). Others are in preparation and are to come.
See more
Successful rigging of Cyclone® KIUBE in Sun Yat-sen University Cancer Center(SYSUCC) in Guangzhou
With the Cyclone® KIUBE 100 equipped with ¹⁸F, ¹³N, ¹¹C and Solid Plus Nirta® targets and radiosynthesizer Synthera®+ with HPLC, loader, extension, Highmore and purification, Sun Yat-sen University Cancer Center(SYSUCC) will be able to deliver FDG and meet increasing demand for various radioisotopes in China.
See more
IBA reports solid Full Year 2024 results
IBA, the world leader in particle accelerator technology and the world’s leading provider of radiopharmaceutical production solutions, today announces consolidated results for the 2024 financial year.
See more
Women In Science: Inspiring the Next Generation
On the International Day of Women in Science, we celebrate the brilliant minds of women shaping the future of science.
See moreFramatome and IBA to partner to develop an Astatine-211 Cyclotron Network in Europe and the USA
Framatome and IBA today announced they have signed a Memorandum Of Understanding to start a strategic partnership aimed at advancing industrial-scale production of Astatine-211 (211At), an alpha-emitting radioisotope across Europe and the United States.
See more
Trends for Nuclear Medicine in 2025
Discover our new series with Prof Dr Rudi Dierckx, a globally renowned expert. The field of Nuclear Medicine is experiencing continuous growth driven by an increasing clinical demand for diagnosis and therapies. Through short capsules weekly published, Prof Dr Rudi Dierckx delves into the major trends shaping the field in 2025.
See more
LIVE WEBINAR 27/01 | Targeted Alpha Therapy: Navigating the Path to Clinical Implementation and Future Outlook
LIVE WEBINAR 27/01/2025 - IBA RadioPharma Solutions | Targeted Alpha Therapy: Navigating the Path to Clinical Implementation and Future Outlook | Prof Dr Giesel & Prof Dr Levillain
See more
Best wishes from our entire IBA RadioPharma Solutions team!
Best wishes from our entire IBA RadioPharma Solutions team!
See more